Back to results
US 12,767,635 B2Granted
Lipoxygenase inhibitors
AssigneeSRI International
InventorsLing Jong, Raymond Ng, Nathan Collins
Life of this patent
Estimating the term…
Abstract
Various embodiments of the present disclosure are directed to compounds having Formula (I), Formula (IA), Formula (IB), Formula (IC), Formula (ID), Formula (IE), and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases, and/or treating associated diseases, such as Alzheimer's disease. In some embodiments, the compounds may be administered to a patient as part of a pharmaceutical formulation.
Claims7
A compound of Formula I:
- wherein the compound is selected from:
- and pharmaceutically acceptable salts thereof.
A compound of Formula IA:
- wherein the compound is selected from:
- and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.